Dengfeng Ren
- Topics
- Breast Cancer Treatment Studies (15 papers)HER2/EGFR in Cancer Research (12 papers)Cancer Treatment and Pharmacology (9 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Dengfeng Ren
43 papers receiving 819 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 535
- Pulmonary and Respiratory Medicine 346
- Molecular Biology 180
- Cancer Research 149
- Surgery 105
Countries citing papers authored by Dengfeng Ren
This map shows the geographic impact of Dengfeng Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengfeng Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengfeng Ren more than expected).
Fields of papers citing papers by Dengfeng Ren
This network shows the impact of papers produced by Dengfeng Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengfeng Ren. The network helps show where Dengfeng Ren may publish in the future.
Co-authorship network of co-authors of Dengfeng Ren
This figure shows the co-authorship network connecting the top 25 collaborators of Dengfeng Ren. A scholar is included among the top collaborators of Dengfeng Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dengfeng Ren. Dengfeng Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 8 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 6 | |
| 11 | 6 | |
| 12 | 17 | |
| 13 | 2 | |
| 14 | 7 | |
| 15 | 13 | |
| 16 | 7 | |
| 17 | 15 | |
| 18 | 5 | |
| 19 | 6 | |
| 20 | Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical developmentbreakdown → | 446 |
About Dengfeng Ren
Dengfeng Ren is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 825 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (535 citations), Pulmonary and Respiratory Medicine (346 citations) and Cancer Research (149 citations). Dengfeng Ren has collaborated with scholars based in China and United States. Frequent co-authors include Fuxing Zhao, Jiuda Zhao, Guoshuang Shen, Feng Du, Raees Ahmad, Fangchao Zheng, Qiuxia Dong, Ziyi Wang, Jinming Li and Yong‐Hui Zheng. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.